Literature DB >> 24385337

The association between drugs frequently used by the elderly and vitamin D blood levels: a review of observational and experimental studies.

Anne Claire B van Orten-Luiten1, André Janse, Rosalie A M Dhonukshe-Rutten, Renger F Witkamp.   

Abstract

The risk of adverse drug reactions (ADRs) rises with increasing age. In the field of ADRs, drug-nutrient interactions (DNIs) are a relatively unexplored area. More knowledge will contribute to the simple prevention of this type of ADR. As the prevalence of vitamin D deficiency in the elderly is high, the primary objective of this review is to evaluate the literature on the relationship between drug use and vitamin D status, focusing on medicines commonly used by the elderly. PubMed was searched for human epidemiological and clinical studies published until early 2013, investigating the relationship between vitamin D blood levels and use of drugs from one of the following groups: proton pump inhibitors (PPIs), biguanides, vitamin K antagonists, platelet aggregation inhibitors, thiazide diuretics, loop diuretics, beta-blocking agents, calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, angiotensin-II antagonists, statins, benzodiazepines, and antidepressants. A total of 63 publications were identified. Thiazide diuretics, statins, and calcium channel blocking agents were the most frequently studied drug groups. Associations between thiazides and vitamin D were mixed (n = 22), statins had no or positive associations (n = 16) and calcium blockers were not associated or were negatively associated with vitamin D (n = 10). In conclusion, several knowledge gaps exist on the relationship between drug use and vitamin D blood levels. Available data are scarce (particularly for the aged), study characteristics are highly variable, and found associations may be confounded by, amongst other things, the underlying disease. Nonetheless, this review provides a basis for future research on ADRs that contribute to nutrient deficiencies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24385337     DOI: 10.1007/s40266-013-0137-1

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  83 in total

1.  Effect of dipyridamole on serum and urinary phosphate in X-linked hypophosphatemia.

Authors:  M G Seikaly; R Quigley; M Baum
Journal:  Pediatr Nephrol       Date:  2000-11       Impact factor: 3.714

2.  Inhibiting gastric acid production does not affect intestinal calcium absorption in young, healthy individuals: a randomized, crossover, controlled clinical trial.

Authors:  Matthew J Wright; Rebecca R Sullivan; Erin Gaffney-Stomberg; Donna M Caseria; Kimberly O O'Brien; Deborah D Proctor; Christine A Simpson; Jane E Kerstetter; Karl L Insogna
Journal:  J Bone Miner Res       Date:  2010-10       Impact factor: 6.741

3.  The antihypertensive effects of calcium channel blockade: role of sodium and calcium metabolism.

Authors:  L M Resnick; J P Nicholson; J H Laragh
Journal:  J Cardiovasc Pharmacol       Date:  1988       Impact factor: 3.105

4.  Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women's Health Initiative Calcium plus Vitamin D clinical trial.

Authors:  Amy E Millen; Jean Wactawski-Wende; Mary Pettinger; Michal L Melamed; Frances A Tylavsky; Simin Liu; John Robbins; Andrea Z LaCroix; Meryl S LeBoff; Rebecca D Jackson
Journal:  Am J Clin Nutr       Date:  2010-03-10       Impact factor: 7.045

5.  Effects of long-term treatment with loop diuretics on bone mineral density, calcitropic hormones and bone turnover.

Authors:  L Rejnmark; P Vestergaard; L Heickendorff; F Andreasen; L Mosekilde
Journal:  J Intern Med       Date:  2005-02       Impact factor: 8.989

6.  Vitamin D deficiency parallels inflammation and immune activation, the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.

Authors:  Christian Murr; Stefan Pilz; Tanja B Grammer; Marcus E Kleber; Andreas Meinitzer; Bernhard O Boehm; Winfried Marz; Dietmar Fuchs
Journal:  Clin Chem Lab Med       Date:  2012-12       Impact factor: 3.694

7.  Verapamil-induced natriuretic and diuretic effects: dependency on sodium intake.

Authors:  G S Hughes; T D Cowart; M J Oexmann; E C Conradi
Journal:  Clin Pharmacol Ther       Date:  1988-10       Impact factor: 6.875

Review 8.  Vitamin K and bone health in adult humans.

Authors:  Susanne Bügel
Journal:  Vitam Horm       Date:  2008       Impact factor: 3.421

9.  Frusemide therapy and intact parathyroid hormone plasma concentrations in chronic renal insufficiency.

Authors:  H Reichel; B Deibert; S Geberth; H Schmidt-Gayk; E Ritz
Journal:  Nephrol Dial Transplant       Date:  1992       Impact factor: 5.992

Review 10.  Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring.

Authors:  Shu-Feng Zhou; Charlie Changli Xue; Xue-Qing Yu; Chunguang Li; Guangji Wang
Journal:  Ther Drug Monit       Date:  2007-12       Impact factor: 3.681

View more
  1 in total

1.  Vitamin D deficiency as adverse drug reaction? A cross-sectional study in Dutch geriatric outpatients.

Authors:  A C B van Orten-Luiten; A Janse; R A M Dhonukshe-Rutten; R F Witkamp
Journal:  Eur J Clin Pharmacol       Date:  2016-02-12       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.